Stenotrophomonas maltophilia infections: Current status on first-line therapy and other treatment options

18 May 2026
0

Stenotrophomonas maltophilia infections: Current status on first-line therapy and other treatment options

Charoenlap N, Poomchuchit S, Mongkolsuk S, Vattanaviboon P

Acta Microbiol Immunol Hung. 2026. doi:10.1556/030.2026.02883

Tags

Share this

Related Posts

The esterase B from Sphingobium sp. SM42 has the new de-arenethiolase activity against cephalosporin antibiotics. Sungkeeree P, Toewiwat N, Whangsuk W, Ploypradith P, Mongkolsuk S, Loprasert S. Biochem Biophys Res Commun. 2018 Nov 17;506(1):231-236. doi: 10.1016/j.bbrc.2018.10.078. Epub 2018 Oct 19.
Likhitwitayawuid, K.; Sornsute, A.; Sritularak, B.; Ploypradith, P. Chemical Transformations of Oxyresveratrol (trans-2,4,3’,5’-tetrahydroxystilbene) into a Potent Tyrosinase Inhibitor and a Strong Cytotoxic Agent.  Bioorg. Med. Chem. Lett. 2006, 16, 5650–5653.

Recent Posts